BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.93B |
| 2 |
Amazon
AMZN
|
+$430M |
| 3 |
Microsoft
MSFT
|
+$344M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$323M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$345M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$305M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$305M |
| 4 |
PPLI
People Inc
PPLI
|
+$203M |
| 5 |
Visa
V
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12% |
| 2 | Consumer Discretionary | 7.3% |
| 3 | Healthcare | 5.39% |
| 4 | Financials | 5.24% |
| 5 | Communication Services | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $364K | ﹤0.01% |
8,412
-24,082
| -74% | -$1.05M |
|
2277
Global Net Lease
GNL
$1.85B
| $363K | ﹤0.01% |
22,846
+15,518
| +212% | +$262K |
|
|
ARI
2278
Apollo Commercial Real Estate
ARI
$876M
| $363K | ﹤0.01% |
40,316
+25,278
| +168% | +$233K |
|
2279
CNO Financial Group
CNO
$5.11B
| $363K | ﹤0.01% |
22,633
+2,393
| +12% | +$38.4K |
|
2280
Cheesecake Factory
CAKE
$5.64B
| $360K | ﹤0.01% |
12,992
+6,935
| +114% | +$182K |
|
2281
Penumbra
PEN
$12.9B
| $360K | ﹤0.01% |
1,853
-85
| -4% | -$17.9K |
|
2282
Resideo Technologies
REZI
$3.1B
| $360K | ﹤0.01% |
32,710
+21,287
| +186% | +$270K |
|
2283
Sally Beauty Holdings
SBH
$1.54B
| $358K | ﹤0.01% |
41,206
+25,541
| +163% | +$307K |
|
2284
Oil States International
OIS
$539M
| $358K | ﹤0.01% |
130,975
+21,172
| +19% | +$91.9K |
|
|
PRFT
2285
DELISTED
Perficient Inc
PRFT
| $357K | ﹤0.01% |
8,363
-9,144
| -52% | -$368K |
|
2286
Globus Medical
GMED
$11.5B
| $357K | ﹤0.01% |
7,205
-11,887
| -62% | -$613K |
|
2287
QuidelOrtho
QDEL
$981M
| $356K | ﹤0.01% |
1,625
-5,595
| -77% | -$1.25M |
|
2288
Seres Therapeutics
MCRB
$45.6M
| $354K | ﹤0.01% |
626
+529
| +545% | +$176K |
|
2289
LivaNova
LIVN
$4.53B
| $354K | ﹤0.01% |
7,832
+3,957
| +102% | +$191K |
|
2290
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.38B
| $353K | ﹤0.01% |
3,841
+296
| +8% | +$27.1K |
|
|
SLCA
2291
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $352K | ﹤0.01% |
117,326
+60,051
| +105% | +$223K |
|
2292
Otter Tail
OTTR
$3.9B
| $352K | ﹤0.01% |
9,727
+7,002
| +257% | +$269K |
|
|
B
2293
PUT
Barrick Mining
B
$68.5B
| $351K | ﹤0.01% |
+125
| New | +$3.56K |
|
2294
Piper Sandler
PIPR
$5.41B
| $351K | ﹤0.01% |
19,248
+10,016
| +108% | +$171K |
|
2295
Hilltop Holdings
HTH
$2.27B
| $349K | ﹤0.01% |
16,947
+12,310
| +265% | +$239K |
|
2296
Rush Enterprises Class A
RUSHA
$9.6B
| $349K | ﹤0.01% |
15,525
+9,875
| +175% | +$210K |
|
2297
Warrior Met Coal
HCC
$5.19B
| $349K | ﹤0.01% |
20,409
+9,298
| +84% | +$151K |
|
2298
GSK
GSK
$99.2B
| $348K | ﹤0.01% |
7,395
-339
| -4% | -$17K |
|
|
PDCE
2299
DELISTED
PDC Energy, Inc.
PDCE
| $347K | ﹤0.01% |
27,988
+14,665
| +110% | +$209K |
|
2300
Axos Financial
AX
$5.8B
| $346K | ﹤0.01% |
14,833
+9,842
| +197% | +$225K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2020 Portfolio in Review
As of Q3 2020, BNP Paribas Financial Markets held 4,385 positions worth $69.9B, up 23% from $56.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
BNP Paribas Financial Markets deployed $2.99B of net new capital in Q3 2020, opening 85 new positions and adding to 2,667 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 270,001 shares worth $19.9M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P Biotech ETF, an estimated $345M trimmed.
- BNP Paribas Financial Markets's largest Q3 2020 buy was iShares MSCI USA Value Factor ETF: 270,001 shares worth $19.9M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q3 2020, an estimated $1.93B increase.
- BNP Paribas Financial Markets's biggest Q3 2020 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $345M.
- BNP Paribas Financial Markets fully exited People Inc in Q3 2020, selling an estimated $203M.
- BNP Paribas Financial Markets's ten largest holdings make up 22% of its $69.9B portfolio in Q3 2020.
- BNP Paribas Financial Markets opened 85 new positions and closed 175 in Q3 2020.
- BNP Paribas Financial Markets's portfolio value rose 23% quarter-over-quarter to $69.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2020, filed 30 Oct 2020.